-
Markets
athexgroup.grAthens Exchange GroupRead moreTogether for a unified, stronger European capital market.
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureTrade Mini Bond FuturesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Dairy derivatives
- Salmon derivatives
- Container Freight Futures
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Take control of unpredictable dairy pricesEuropean Dairy DerivativesRead moreFutures and options on butter and skimmed milk powder now trading.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
LEO Pharma owners see market conditions as unsuitable for IPO, CEO says
By Jesus Calero
Nov 16 (Reuters) - LEO Pharma's owners don't think the current market conditions support a stock market listing, its chief executive said on Monday, casting further doubt on the Danish drugmaker's flotation plans for 2026.
Christophe Bourdon told Reuters that an initial public offering remained a "natural and viable option" for the dermatology specialist, while saying that its timing depended both on the company's performance and investors' appetite for new listings.
"The timing of a potential IPO is really in the hands of the two shareholders," Bourdon said, referring to majority owner LEO Foundation with an 80% stake and private equity firm Nordic Capital, which owns the rest.
Bourdon said the owners considered the market environment unsuitable for a listing, without setting out a timetable for when one might take place.
Equity market volatility is growing as investors become more cautious, which has also prompted other companies to delay or scale back planned listings.
LEO Pharma's plans for a market debut appeared to be gathering momentum earlier this year, with media reports suggesting it had selected banks to arrange a potential Copenhagen listing before the end of 2026.
However, more recent reports earlier in November said that market volatility could push the IPO into 2027. LEO Pharma declined to comment on the speculation at the time.
Bourdon said on Monday the company's focus remained on delivering consistent growth and strengthening its business, so that it would be prepared to go public when conditions were right.
Nordic Capital invested €450 million ($496 million) in LEO Pharma in 2021, taking a minority stake as the drugmaker set out plans to prepare for a potential listing within four to five years.
LEO Pharma, which specialises in treatments for skin diseases, has since expanded its portfolio through acquisitions and new drug launches, including eczema treatment Anzupgo and psoriasis drug Spevigo.
($1 = 0.9073 euros)
(Reporting by Jesus Calero in Gdansk, editing by Milla Nissi-Prussak)
Find it fast
Looking for more insights? Explore our other news sections for updates on sustainable finance, companies and financial education